Pola Pharma Inc.

Nihon Nohyaku Co., Ltd.

Matsushita Electric Industrial Co., Ltd.

Panasonic Corporation

Mitutoyo Corporation

Paramount Bed Company, Limited

Kyocera Corporation

Nippon Thompson Co., Ltd.

Nec Communication Systems, Ltd.

Nec Communications Systems, Ltd.

Hirokazu Kobayashi

Taisuke Matsumoto

Makoto Funabiki

Nobuo Kubota

Shinkichi Ikeda

Masayuki Kumazawa

Toyoki Kawahara

Takaaki Masuda

Akira Nozawa

Takeshi Yamamoto

Yoshinori Watanabe

Hiroshi Doi

Hiromi Ueda

Osamu Kawatoko

Takumi Nomura

Hiroyuki Kasai

Keita Yamaguchi

Toshinori Tsuboi

Kazutoshi Ohishi

Junpei Kumagai

Hiroshi Katayanagi

Takeyoshi Obara

Kahori Fujii

Eiko Kosugi

Toyohiko Miki

Shozaburo Tsuji

Azuma Nishio

Hiroaki Kurokawa

Madoka Ito

Kenichi Nakayama

Hiroyuki Fujii

Kunitetsu Makino

Masahiro Shirono

Ikuhiro Aota

Katsumasa Ariyoshi

Takashi Kuriyama

Susumu Tomiyama

Tetsuya Endo

Tatsuya Hagiwara

An information processing apparatus includes a housing in which a distance sensor is placed, fittings attaching the housing to a toilet bowl in a toilet, and a control unit. The sensor measures the distance to an object located in a direction of the inside of a toilet seat installed on the bowl when the seat is placed on the top surface of a rim of the bowl. The control unit detects that a user of the toilet is in a state of sitting on the seat when a first distance being a result of measurement by the sensor is less than a predetermined threshold value. The fittings are components attaching the housing in such a way that the sensor is placed at a position located inside the rim and located under the seat in the vertical direction when the seat is placed on the top surface of the rim.

Information processing apparatus, information processing method, and non-transitory computer-readable medium

An information collection apparatus includes: a sitting sensor detecting that a user of a toilet bowl in a toilet is sitting on a toilet seat placed on the top surface of a rim of the bowl; an information collector collecting information about an excretion in the bowl; and a housing in which the sensor and the collector are placed. The apparatus includes: a bridge component bridging the inside of the rim and the outside of the rim by placing part of the component on the top surface of the rim of the bowl and sandwiching the rim; and a fitting being attached to an end of the component in a direction of the inside of the rim and attaching the housing. The apparatus includes a change mechanism changing the distance from the end to the housing in a direction along an inner wall forming the inside of the rim.

Information collection apparatus and apparatus attaching method

Compositions having an increased amount of an effective component retained in the composition for a pump foamer are provided. A composition for external use is described which contains: 1) an N-alkyl-2-pyrrolidone and/or a diester carbonate; and 2) a surfactant. The composition is in a foam state upon use.

External-use composition producing foamed state upon use

Provided is a product exhibiting good bubbles even from a screen foamer composition using a non-ionic surfactant. This foam contains a non-ionic surfactant and is composed of an air layer and a bubble shell encapsulating the air layer. The bubble shell has a high light transmission region which is optically transparent and a low light transmission region which is less optically transparent than the highlight transmission region, both regions being disposed so as to spread across a surface of the bubble shell in such a manner as to form an identifiable boundary therebetween; and when the foam is allowed to stand at 25&#xb0; C., an area of the low light transmission region occupying the surface area of the bubble shell expands over time, and thus the entire surface of the bubble shell becomes occupied by the low light transmission region.

Foam, screen foamer composition, and evaluation method for same

The present invention addresses the issue of providing an external composition for screen foamers such as pump foamers, that can be safely used even when not removed after application. Provided is an external composition for screen foamers, including a non-ionic surfactant as a foaming component and, ideally, being in a soluble state.

External composition for screen foamers

In a pharmaceutical composition for external use containing a compound such as luliconazole and/or a salt thereof in an amount of 5% by mass or more, comprised is/are acetone, a polyoxyethylene alkyl (having 8 to 30 carbon atoms) ether, and/or a polyoxyethylene alkenyl (having 8 to 30 carbon atoms) ether. Provided is a preparation using a solvent other than crotamiton, propylene carbonate, and N-methyl-2-pyrrolidone as a solvent for solubilization and steric stabilization and having the following properties: 1) when a compound represented by the general formula (1) and/or a salt thereof has a stereoisomer, the amount of the stereoisomer of the compound and/or a salt thereof produced under a preservation condition of 60&#xb0; C. for 3 weeks is 1% by mass or less with respect to the total mass of the compound and/or a salt thereof at the beginning of preservation; 2) the preparation is in a clear liquid state when preserved at a constant temperature of 20&#xb0; C. immediately after manufacture; and 3) no crystal is deposited when the preparation is preserved at 5&#xb0; C. for 2 weeks after manufacture.

Antimycotic pharmaceutical composition

Provided is a means for stably storing a pharmaceutical composition comprising a compound represented by the General Formula (I) below and/or a salt thereof, and for providing the pharmaceutical composition to the market. A resin container colored with a color having a hue (H) within the range of 7.0Y to 9.99Y or 7.0YR to 9.99YR, value (V) within the range of 1.0 to 6.0, and chroma (C) within the range of 0.5 to 7.5, according to Munsell color coordinates, is filled with a pharmaceutical composition comprising a compound represented by the General Formula (I) and/or a salt thereof, to store the pharmaceutical composition. (wherein, in the formula, Rand Reach independently represent a hydrogen atom or a halogen atom)

Resin container filled with antifungal pharmaceutical composition

In a photoelectric absolute encoder including a scale having a plurality of tracks with different pitch patterns, and a detector having a light source and light receiving elements including a plurality of light receiving element arrays corresponding to the plurality of tracks, a light receiving element array is additionally arranged at a position in the detector corresponding to a boundary between the track having a pattern with a wide pitch and the track having a pattern with a narrow pitch adjacent to each other in the scale, and displacement of the detector relative to the scale in a lateral direction is detected from a signal amplitude of the added light receiving element array. In this manner, displacement of the detector relative to the scale in the lateral direction can be detected.

Photoelectric absolute encoder having a light receiving element array additionally arranged corresponding to a boundary between the track having a wide pitch pattern and a narrow pitch pattern and installation method therefor

In a pharmaceutical composition for external use containing a compound such as luliconazole and/or a salt thereof, comprised are a higher alcohol which is in a liquid state at 1 atm and 25&#xb0; C. and/or a diester of a dibasic acid, provided that a diester carbonate is excluded, and a polyoxyethylene alkyl ether and/or a polyoxyethylene alkenyl ether. Provided is a preparation using a solvent other than crotamiton, propylene carbonate, and N-methyl-2-pyrroridone as a solvent for solubilization and steric stabilization and having the following properties: 1) when a compound represented by the general formula (1) and/or a salt thereof has a stereoisomer, the amount of the stereoisomer of the compound and/or a salt thereof produced under a preservation condition of 60 degrees C. for 3 weeks is 1% by mass or less with respect to the total mass of the compound and/or a salt thereof at the beginning of preservation; 2) the preparation is in a clear liquid state when preserved at a constant temperature of 20&#xb0; C. immediately after manufacture; and 3) no crystal is deposited when the preparation is preserved at 5&#xb0; C. for 2 weeks after manufacture.

An object is to provide a medicament preparation which is excellent in the solubilization stability in relation to a compound represented by the general formula (1) during the storage in a low temperature region and a high temperature region. The present invention resides in a pharmaceutical composition comprising 1) the compound represented by the general formula (1) and/or a salt thereof and 2) a polyhydric alcohol derivative. General formula (1) (In the formula, R, Rindependently represent hydrogen atom or halogen atom respectively, and at least one of R, Ris halogen atom.) 

A pharmaceutical composition which comprises 1) a compound represented by the following general formula (1) and/or a salt thereof; and 2) a ketone such as methyl ethyl ketone. Preferably, the compound represented by the following general formula (1) is luliconazole, where R&#x2550;R=a chlorine atom: where Rand Reach independently represents a hydrogen atom or a halogen atom, and at least one of Rand Rrepresents a halogen atom. The present invention provides a preparation excellent in solubilization stability for a compound represented by the general formula (1) and/or a salt thereof in low-temperature or high-temperature storage. 

An inductive detection encoder according to the present invention includes: first and second members which are oppositely disposed so as to relatively move in a measurement direction; a transmitting coil formed in the first member; a magnetic flux coupled body which is formed in the second member and coupled with a magnetic field generated by the transmitting coil; and a receiving coil formed in the first member and having receiving loops. At least one of the transmitting coil and the receiving coil has a specific pattern that impairs the uniformity and periodicity of a pattern; and a dummy pattern formed in a position corresponding to a specific phase relationship of a cycle generated by the track with respect to the specific pattern.

Inductive detection encoder and digital micrometer

An induction detecting type rotary encoder includes: a stator; a rotor configured to be rotated with respect to a rotary shaft; a first transmitting coil; a second transmitting coil; a first receiving coil; a second receiving coil; a first magnetic flux coupling body; and a second magnetic flux coupling body. The first transmitting coil is disposed between the first and second receiving coils. A distance between the second transmitting coil and the rotary shaft is larger than that of the second receiving coil and the rotary shaft. The first magnetic flux coupling body forms a first track for causing a periodic change for each rotation. The second magnetic flux coupling body forms a second track for causing a periodic change for each rotation. The second magnetic flux coupling body has a pattern of which an inner peripheral side is substantially continuous in a circumferential direction.

Induction detecting type rotary encoder

A pharmaceutical composition for external use, including: i) luliconazole represented by the following structural formula (1) and/or a salt thereof; and ii) one or two or more selected from N-methyl-2-pyrrolidone, propylene carbonate, and crotamiton. 

Pharmaceutical composition for external use

The present invention is to provide an optical access network in which a remote unit receives an optical burst signal. A central unit (OLT) transmits a DC-balanced optical continuous signal including packets having identification information for identifying each remote unit (ONU) to an optical switching module (OSM). The optical switching module (OSM) receives the DC-balanced optical continuous signal from the central unit (OLT), optically switches the packets based on the identification information, and transmits a DC-balanced optical burst signal including the packets to the remote unit (ONU). The remote unit (ONU) receives the DC-balanced optical burst signal and acquires the packets transmitted to the remote unit (ONU).

Optical access network, remote unit, optical communication method, and optical communication program

Growing community of inventors

Yokohama, Japan

Hirokazu Kobayashi